Editorial commentary on: "Reduced vs full-dose BCG therapy in bladder cancer: A systematic review and meta-analysis"
Actas Urol Esp (Engl Ed). 2023 Jan-Feb;47(1):1-3.
doi: 10.1016/j.acuroe.2022.09.002.
Epub 2022 Oct 6.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Urology, Torrejon University Hospital, Universidad Francisco de Vitoria, Madrid, Spain; Instituto de Cirugía Urológica Avanzada (ICUA), Clínica CEMTRO, Madrid, Spain; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group. Electronic address: dmcarrion@torrejonsalud.com.
- 2 European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group; Department of Urology UROSUD, Croix Du Sud Hospital, Quint-Fonsegrives, France; Department of Urology, Medical University of Vienna, Vienna, Austria.
- 3 European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group; Department of Urology, AOU Citta della Salute e della Scienza, Torino School of Medicine, Turin, Italy.
- 4 European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group; Department of Maternal Infant and Urologic Sciences, Sapienza University of Rome, Policlinico Umberto I Hospital, Rome, Italy.
- 5 European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group; Department of Urology, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.
No abstract available
Publication types
-
Meta-Analysis
-
Systematic Review
-
Editorial
MeSH terms
-
Adjuvants, Immunologic / therapeutic use
-
BCG Vaccine* / therapeutic use
-
Humans
-
Urinary Bladder Neoplasms* / drug therapy
Substances
-
BCG Vaccine
-
Adjuvants, Immunologic